BACKGROUND: Introducing evidence-based exercise guidelines of Parkinson's disease (PD) into clinical practice and community settings has been highlighted. AIM: This study tested the feasibility and compared the weekly effects of a 12-week walking training program on PD patients and community-dwelling seniors. DESIGN: A prospective quasi-experimental design was used. PD patients in Hoehn and Yahr Stage I through III (PG) and community-dwelling adults older than 65 were recruited (CG). METHODS: In the outpatient department of a hospital, the information of personal data, coordination test, and walking ability of participants were collected first. They then participated in a 36-session, 12-week treadmill walking training program. RESULTS: Weekly data of step length and velocity in PG and CG were collected. The walking training program achieved significant velocity (χ² = 126.38, p < 0.001) and step length (χ² = 27.27, p = 0.001) improvements in PG. Differences in improvement between PG and CG in terms of velocity (χ² = 7.089, df = 1, p = 0.008) and step length (χ² = 7.718, df = 1, p = 0.005) were also identified. CONCLUSION: The applicability of this 12-week walking program both for PD patients and community-dwelling older adults was identified. Conducting the economic evaluation and neurology studies of the 12-week walking program and test the effects of five-week walking program are suggested.
BACKGROUND: Introducing evidence-based exercise guidelines of Parkinson's disease (PD) into clinical practice and community settings has been highlighted. AIM: This study tested the feasibility and compared the weekly effects of a 12-week walking training program on PDpatients and community-dwelling seniors. DESIGN: A prospective quasi-experimental design was used. PDpatients in Hoehn and Yahr Stage I through III (PG) and community-dwelling adults older than 65 were recruited (CG). METHODS: In the outpatient department of a hospital, the information of personal data, coordination test, and walking ability of participants were collected first. They then participated in a 36-session, 12-week treadmill walking training program. RESULTS: Weekly data of step length and velocity in PG and CG were collected. The walking training program achieved significant velocity (χ² = 126.38, p < 0.001) and step length (χ² = 27.27, p = 0.001) improvements in PG. Differences in improvement between PG and CG in terms of velocity (χ² = 7.089, df = 1, p = 0.008) and step length (χ² = 7.718, df = 1, p = 0.005) were also identified. CONCLUSION: The applicability of this 12-week walking program both for PDpatients and community-dwelling older adults was identified. Conducting the economic evaluation and neurology studies of the 12-week walking program and test the effects of five-week walking program are suggested.